Exogenous ethephon treatment on the biosynthesis and accumulation of astragaloside IV in Astragalus membranaceus Bge. var. mongholicus (Bge.) Hsiao

Author:

Wu Haonan1,Tian Yu1,Wu Jiawen1,Bai Zhenqing1ORCID,Zhang Xiujuan2

Affiliation:

1. Yan'an University

2. Inner Mongolia Academy of science and technology

Abstract

Abstract Background Astragaloside IV, a prominent secondary metabolite found in Astragalus membranaceus Bge. var. mongholicus (Bge.) Hsiao (A. membranaceus), serves as a crucial indicator of A. membranaceus quality. Ethylene, acting as an exogenous signal, plays a role in regulating secondary metabolism in plants. In this study, the application of ethephon (Eth) to hydroponically cultivated A. membranaceus was employed to investigate the biosynthesis of astragaloside IV in the roots, involving both content measurement and analysis of key gene expression. Results The results demonstrated that the significantly accumulation of astragaloside IV was observed on the 3rd day after 200 µmol·L− 1 Eth treatment, reaching 0.269%. Among the 10 key genes involved in astragaloside IV synthesis, HMGS, FPS, CAS, CYP88D6, and CYP93E3 were found to be insensitive to Eth. On the other hand, the expression levels of AACT, HMGR, IDI, and SS exhibited a significant increase at 12 hours under Eth treatment, followed by a notable decrease at 3rd day. Additionally, SE displayed a significant decrease at 12 hours and a subsequent increase in the 3rd day under Eth treatment. The expression level of FPS, HMGR, IDI, SS, and CYP93E3 exhibited significant negative correlations with astragaloside IV content, while expression level of SE displayed a significant positive correlation. Conclusions These findings suggest that exogenous Eth treatment can potentially influence the synthesis of astragaloside IV by modulating the expression of FPS, HMGR, IDI, SS, CYP93E3 and SE. This study provides a theoretical basis for utilizing molecular strategies to enhance the quality of A. membranaceus.

Publisher

Research Square Platform LLC

Reference36 articles.

1. National Pharmacopoeia Committee (2020) Pharmacopoeia of the People's Republic of China. China Medical Science and Technology Press, Beijing, China

2. Astragaloside IV inhibits cell proliferation and metastasis of breast cancer via promoting the long noncoding RNA TRHDE-AS1;Hu S;J Nat Med,2021

3. A comparative study on the effect of promoting the osteogenic function of osteoblasts using isoflavones from Radix Astragalus;Kong X;Phytother Res,2018

4. Calycosin-7-O-β-D-glucoside reduces myocardial injury in heat stroke rats;Tsai CC;J Formos Med Association = Taiwan yi zhi,2019

5. Astragaloside IV ameliorates radiation-induced senescence via antioxidative mechanism;Liu X;J Pharm Pharmacol,2020

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3